Healthcare

Nudj Health and Corewell Health Announce Ground-Breaking New Cost and Utilization Data Highlighting Significant Cost-Savings of its Whole-Person Care Model

Results announced at the American College of Lifestyle Medicine Annual Conference in Dallas, Texas DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE)...

Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges

Teva Launches Teva Rise Teva Launches Rise - Global Open Innovation Platform First cohort features 7 real-world challenges across R&D,...

Libtayo® (cemiplimab) Approved in the European Union as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with High Risk of Recurrence after Surgery and Radiation

error: Content is protected !!